⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LNTH News
Lantheus Holdings, Inc
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
globenewswire.com
LNTH
Halper Sadeh LLC is Investigating Whether LNTH, BOW, SAFT are Obtaining Fair Deals for their Shareholders
globenewswire.com
LNTH
BOW
SAFT
Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders?
prnewswire.com
DSGR
LNTH
ATKR
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
businesswire.com
LNTH
Form 8-K
sec.gov
LNTH
Lantheus Reports Second Quarter 2026 Financial Results
globenewswire.com
LNTH
Lantheus Reports Second Quarter 2026 Financial Results
globenewswire.com
LNTH
Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their Shareholders
globenewswire.com
MKTX
SMTI
LNTH
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insurance Group Inc. (Nasdaq – SAFT), Neuphoria Therapeutics Inc. (Nasdaq
globenewswire.com
BOW
LNTH
SAFT
NEUP
Form 8-K
sec.gov
LNTH